Bio-Strategy Appointed To Merck Dealership

17 September, 2004
Media statement

Bio-Strategy Appointed To Merck Dealership

Statement made by Dr Earl Stevens, Managing Director,
Bio-Strategy Group

Bio-Strategy Distribution has been appointed a New Zealand distributor of Merck Limited, the New Zealand operation of Merck KGaA, one of the world’s largest manufacturers and suppliers of laboratory products, consumables and apparatus.

The appointment is a major success for Bio-Strategy, and recognises our growing reputation as a true biotech specialist and partner.

Our strength comes from linking our biotech and international business experience and expertise with an understanding of what our customers are seeking from laboratory products, consumables and apparatus. With our in-depth knowledge of the industry, we can add value to customers’ purchase decisions.

The short space of time in which we have assembled a comprehensive range of global suppliers to support the life science, diagnostics and technology industries is proof of our industry knowledge.

To have received recognition from a world leader such as Merck after being in operation for some 12 months as a distributor is another excellent endorsement of the value they see in this think tank, value added approach.

We now represent more than 50 overseas principals, and offer more than 20,000 biotech products.

We make extensive use of information technology to short circuit delivery times, whether we are supplying from New Zealand or from principals in North America or Europe.

ENDS

© Scoop Media